Senior Analyst, Corporate Development & Investor Relations at Beta Bionics in San Diego, CA

Job description

About Beta Bionics Beta Bionics, Inc. is a medical technology company dedicated to bringing innovative type 1 diabetes management solutions to the many, not the few. We are committed to bringing better access to better solutions – and a better life for those living with diabetes – with the world’s first bionic pancreas called the iLet. The iLet Bionic Pancreas is the first and only insulin delivery system that does not require carb counting*, bolusing, correction factors, or pre-set basal rates. The only number needed to get started with the iLet Bionic Pancreas is a user’s weight – the iLet does the rest. The iLet lets users “Go Bionic” with their diabetes management. *User must be carb aware. Successful candidates will be working with highly experienced colleagues, who are amongst the best in their fields. We have a mission-driven, passionate and collaborative culture where you will have a high degree of empowerment and opportunity to make a significant impact. Please contact us if you fit the profile below and if you are interested in joining the Beta Bionics team! Location - San Diego, CA. This is an on-site/in-person role . Summary/Objective This role is for someone with a finance background who enjoys operating beyond the traditional boundaries of a finance role. Beta Bionics is a fast-paced, entrepreneurial environment. The perfect candidate is the kind of person who is excited to take on whatever the business needs to win. While the role is expected to focus on Corporate Development, Investor Relations, and Clinical Trials, its scope will likely evolve over time based on the needs and priorities of the business. The Senior Analyst will support the Corporate Development and Investor Relations functions while also contributing to Clinical Operations initiatives that intersect with strategic and financial priorities. This is a cross-functional role suited to an individual who can leverage financial, commercial, and clinical analysis to support M&A and strategic partnership initiatives, develop and communicate investor-facing narratives, and identify and execute on opportunities for business growth with a particular emphasis on clinical trials that shape the future of the company. This is a highly visible role, both internally and externally, reporting directly to the Head of Corporate Development and Investor Relations, collaborating frequently with C-level executives, and engaging with the capital markets. Essential Duties and Responsibilities [Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions. Qualified candidates who need a reasonable accommodation with the application process and/or to perform the essential functions of the position should notify the company’s HR contact] Corporate Development Support evaluation of potential partnerships, licensing deals, and M&A opportunities, including market research, financial modeling, and due diligence Identify opportunities for corporate growth both commercially and clinically, and build business cases and valuation analyses to support strategic business initiatives Learn and monitor the diabetes technology and therapeutics landscape, including industry trends, competitor activity, and the M&A landscape Investor Relations Support preparation of earnings materials, investor presentations and events, and quarterly reports Monitor sell-side analyst models, consensus estimates, and peer/competitor performance Participate in sell-side analyst and investor meetings and conferences (some travel required) Maintain investor website content, shareholder databases, and distribution lists Clinical Strategy & Operations Partner with the Clinical Operations team to execute on key business growth initiatives that require early and/or late-stage clinical trials Support the development of key partnerships with clinical research institutions and clinical research vendors to initiate and execute clinical trials in an efficient manner